James Clubb
MSc, Project Manager
James Clubb has expertise in the development of cell and gene therapies and preclinical research tools. James is currently completing his PhD as Marie Skłodowska-Curie fellow, during which he evaluated TILT-123 as a potential new treatment option for head and neck cancer using novel preclinical models. James is now responsible for the development and management of TILTs’ clinical trial sample analyses.
